Genetic enhancement and the fate of the worse off.
When reflecting on arguments in the debate about genetic technologies, decision makers must try to be empathetic to those who are worse off. Disparities in health and health care in the U.S. pale when global facts are considered. Although U.S. citizens ought to be concerned about the worse off in the U.S., such concern ultimately must be balanced against the urgent imperative to address the plight of those in poor countries. It is a matter of fairness that care and concern be directed to those who are truly worse off in global terms.
Mwase
Isaac M T
IM
Tuskegee University, National Center for Bioethics in Research, USA.
D019049:Developed Countries; D003906:Developing Countries; D026689:Ethical Analysis; D028663:Ethical Theory; D005006:Ethnicity; D024861:Genetic Enhancement / Q000941:ethics*; D005854:Germ Cells; D006297:Health Services Accessibility / Q000941:ethics; D006304:Health Status; D006801:Humans; D030821:Plants, Genetically Modified; D011640:Public Policy; D040841:Resource Allocation / Q000941:ethics; D012926:Social Control, Formal; D012935:Social Justice; D012959:Socioeconomic Factors; D014481:United States